el impacto de la validacion de sistemas criticos en la calidad de los medicamentos homeopaticos

8/17/2019 El Impacto de La Validacion de Sistemas Criticos en La Calidad de Los Medicamentos Homeopaticos

1/35

! !"#$%&' )* +$ ,$+!)$%!-. )*/!/&*"$/ %01&!%'/ #$%&$ ' $()*

$+,(*-.$/0 *. +$ %$+!)$) )* +'/"*)!%$"*.&'/ 2'"*'#3&!%'/ !

!"#$ &'()(*+ ,-.)/+") &+"01/'0


2/35

!4 ,5678597:;

!;?5?8@ *A956@;5 =@;BC6>B D />EFGHI F

! *J78>;975 8@9KL>;M56 ;>?585 5 M?5JNA 8> 65?>9@E76597:; O >J56K597:; 8> 6@A 85M@A @PM>;78@A >;65 9567Q9597:; O 8> 65A E?K>P5A >AE>9RQ95AS P5A585A

>; 9@;@97L7>;M@ 8>6 E?@9>A@S A7AM>L5 @ LNM@8@SE5?5 8>L@AM?5? TK;97@;567858S 9@;A7AM>;975 O?@PKAM>B42

345 6789::;9 ?@A'")- B(1.C.)- *' D)E(F.).FG" *' 5'*F.)H'"I+-2$


3/35

!4 ,5678597:; U9@;M44V

!;?5?8@ *A956@;5 =@;BC6>B D />EFGHI I

LIBERACIÓN

ORGANIZACIÓN

AREAS

EQUIPOS

INSUMOS

SISTEMAS PERSONAL

PROTOCOLO

EJECUCIÓN

APROBACIÓN RECHAZO

RESULTADOS

REPORTE

METODOS ANALITICOS

SISTEMAS CRITICOS

EQUIPOS Y PROCESOS

INSTALACIONES

PERSONAL

LIMPIEZA

SOFTWARE

REQUISI

TOS

VALI

DACIÓN


4/35

!!4 /7AM>L5A %?RW9@A

• )> 59K>?8@ 5 65A XK>;5A #?C9W95A 8>Y5P?79597:; ZX#Y[A\ U="#[A >; !;


5/35

!!4 /7AM>L5A %?RW9@A U9@;M44V

• &7E@A]

H4 $ $9@;8797@;58@ U2,$%VI4 $7?> %@LE?7L78@ +7P?> 8> $9>7M>

^4 ,5E@? +7LE7@

`4 =5A>A *AE>9756>A U.FS 'FS a _$#Vb4 'M?@A

!;?5?8@ *A956@;5 =@;BC6>B D />EFGHI `


6/35

H4 $B D />EFGHI b

H4H #?@P6>L5 8> 65 #K?>B5

a %@;M5L7;597:; .5MK?56 O#K?7Q9597:;4

a %@;M5L7;597:; X59M>?75;5

H4F !8>;WQ9597:; 8> !LEK?>B5A

a %K567M5WJ5 =>;>?56a$AE>9M@ a'6@?

a%@6@? a /5P@?

a

%K5;WM5WJ5 =>;>?56aE2 a&'%

a%@8K9WJ7858 a "79?@P7@6:


7/35

H4 $?J797@A #cP679@A 8> $;M@ >; /7W@ – $ $67L>;M597:;

– !;M>?95LP7@ !:;79@ U)!V

– 'AL@A7A !;J>?A5 U0'V

– )>AW6597:; UdY!V

– .5;@Q6M?597:; U.YV

– _6M?5Q6M?597:; U_YV

–

"79?@Q6M?597:; U"YV

!;?5?8@ *A956@;5 =@;BC6>B D />EFGHI e


8/35

H4 $B D />EFGHI f

.123 45 673489:3 673489:3 .123 45 $;8<#)5=> +?@>0

#?@8K9M@A ">8797;56>A*AMN?76>A

a#5?>;M>?56>Aa/@6K97@;>A 8> 2>L@87C67A7Aa/@6K97@;>A 8> )7C67A7A #>?7M@;>56a/@6K97@;>A E5?5 !??7Aa#?>E5?58@A .5A56>A O -W9@Aa#?>E5?58@A KA@ ?>9M56DJ5@A $ ED 97>?M@AKA@A J>M>?7;5?7@A

=?5;K6597:; #K?7Q9585 D #@M5P6> >; KA@ J>M4

0>9KP?7L7>;M@ #K?7Q9585

+7@Q67B58@ #K?7Q9585 h #?@84 *AMN?76 D #@M5P6> h #?@84 .@ *AMN?76

Y K > ; M > ] * K ? @ E > 5 ; " > 8

7 9 7 ; > A * J 5 6 K 5 W @ ; $ < > ; 9 O

U * " * $ V


9/35

H4 $B D />EFGHI i

.123 45 673489:3

AE5?597:;S A7 65 L7AL5 >A 8>9567858 AKE>?7@?4

#?@8K9M@AY5?L59NKW9@A*AMN?76>A#5?>;M>?56>A

a+5J58@ $A .@#5?>;M>?56>A

a+5J58@ $6 5; 65E?>E5?597:;S A7 65 L7AL5 >A 8>9567858 AKE>?7@?4

Y K > ; M > ] * K ? @ E > 5 ; " > 8

7 9 7 ; > A * J 5 6 K 5 W @ ; $ < > ; 9 O

U * " * $ V


10/35

H4 $A54

!;?5?8@ *A956@;5 =@;BC6>B D />EFGHI HG


11/35

H4 $9K>;975AH4b4H )>L@AM?5? kK> >6 58> A>?E?@8K9785 93@H1H:5@:5B5@:5 8>;M?@ 8> >AE>97Q9597@;>A

E5?5 AK KA@ >; 6@A E?@9>A@A 8> T5P?79597:;4

H4b4F *AM5P6>9>? >6 ;7J>6 8> 9@;M?@6 L79?@P7@6:9>A5?7@S kK> ?>kK>?7?C 8>6 >;M>;87L7>;M@ UE6>;@9@;@97L7>;M@V 8> 5LP5A 9@A5A] >6 8H3 45L 273489:3 I 45L

27395H3 45 OB D />EFGHI HH


12/35

H4 $A

&?5M5L7>;M@ 8> 5


13/35

H4 $ A7AM>L5A 8> 5 6@A A7AM>L5A 8> 5P> ?>567B5?A> 9@;T@?L> 5 65 Y*_" O AKA AKE6>L>;M@A4\345 6789::;=9 ?@A'")- B(1.C.)- *' D)E(F.).FG" *' 5'*F.)H'"I+-2

H4e4F +5 J5678597:; E5?5 6@A A7AM>L5A 8> 5 65AA7;M>A >M5E5A]

a %567Q9597:; U%)S %!S %'V

a %@L7A7@;5L7>;M@ U%@LL7AA7@;7;A>LE>m@

!:B, BO)(H).'AC.)/ ,"#F"''(F"# &AF*'$ P+/ Q$ R)I'( )"* :I')H :L-I'H-$

!;?5?8@ *A956@;5 =@;BC6>B D />EFGHI HI


14/35

H4 $ 8> )>A>LE>m@ @ 8> ,5678597:; 9@;AM58> M?>A T5A>A 8> L@;7M@?>@4 +@A W>LE@A E5?5

65A T5A>A A@;]• Y5A> H] F n ^ A>L5;5A

• Y5A> F] ^ A>L5;5A

• Y5A> I] H 5m@

!;?5?8@ *A956@;5 =@;BC6>B D />EFGHI H^


15/35

• )> 59K>?8@ 5 65 Y*_"S K; /7AM>L5 8> $P>?C9KLE67? 9@; 65A A7;M>A >AE>97Q9597@;>A 8> 9567858]

• N


16/35

• %@;96KA7:; 8> 65 ,5678597:;]

• #K>AM5 >; />?J797@ 8>6 /7AM>L5• #?@8K97? 5;M>L>;M> 9D >AE>97Q9597@;>A 8> 9567858 ?>kK>?785A•

*AM5P6>9>? 6@A #?@9>87L7>;M@A 8> 'E>?597:; 8>6 L7AL@• )>Q;7? O L@;7M@?>5? 6@A 6RL7M>A 8> 9@;M?@6 U56>?M5 O 5997:;V• *AM5P6>9>? 65A ?KW;5A 8> "5;M>;7L7>;M@ #?>J>;WJ@

• *67L7;5? TK>;M>A E?@P5P6>A 8> 9@;M5L7;597:; r5975 6@A E?@8K9M@A• /@E@?M> ?> 65 9567858 8> 6@A E?@8K9M@A T5P?7958@A•

%@;@97L7>;M@ 8> 6@A E?@8K9M@A O 6@A E?@9>A@A4• %@AM@A @E>?5WJ@A 9@;M?@658@A O ?>8K978@A D 7;87>;M> E?7;97E56 >; 6@A

E?@9>A@A 8> T5P?79597:; O 67LE7>B5 4

!;?5?8@ *A956@;5 =@;BC6>B D />EFGHI Hb

H4 $


17/35

• )5O575@91 6@A *AM58@A _;78@A ">o795;@A J7;M> UY*_"V4• _;7M>8 /M5M>A #r5?L59@E>75 U_/#V• *K?@E>5; #r5?L59@Er>75 %@LL7AA7@;4

•

*K?@E>5; ">8797;>A *J56K5W@; $;9O U*"*$V• d2' =@@8 "5;KT59MK?7;< #?59W9>A] d5M>? T@? #r5?L59>KW956 _A>

UIi 0>E@?MV• &AS) K)() /) T)/F*)* *'/ ;#A) B+I)E/'U >V$ ,*$ &F"'E() W 45:$


18/35

a 2,$% a

Z/7AM>L5 8> $7?> $9@;8797@;58@ O %56>T5997:;\

E@? AKA A7; 7;5W;;W65W@; 5;8 $7? %@;87W@;7;B D />EFGHI Hf

F4 $7?> $LP7>;M56 a 2,$%


19/35

• -R+ STU VV$W!XSWYZ

• [>X>X>\ +5A C?>5AS >kK7E@A 8> T5P?79597:; OE?@9>A@A 8>P>; 9@;M5? 9@; 6@A A7AM>L5A 9?RW9@A

?>kK>?78@A M56>A 9@L@] 2,$%S 57?> 9@LE?7L78@S5;M?>@M?@A4

• [>X>X>[ *6 A7AM>L5 2,$% 8>P> >AM5? 87A>m58@ 8>

T@?L5 M56 kK> E>?L7M5 9KLE67? 9@; 65 965A7Q9597:;8>6 C?>5 ?>kK>?785 8> 59K>?8@ 56 $EN;879>;@?L5WJ@ $4

!;?5?8@ *A956@;5 =@;BC6>B D />EFGHI Hi

F4 $7?> $LP7>;M56 a 2,$% U9@;M44V


20/35

• [>X>X>WW /> 8>P> >J7M5? kK> 65 7;AM56597:; O >6599>A@ E5?5 L5;M>;7L7>;M@ 56 2,$%S 5L5A 8> A@E@?M> A>5 K;5 TK>;M> 8>9@;M5L7;597:; E5?5 >6 E?@8K9M@4

• [>X>X>WX .@ 8>P> >o7AW? ?>97?9K6597:; 8> 57?>>; 6@A A7AM>L5A 2,$% 8> C?>5A 8@;8> A>

E?@9>A5; @?A O>J7M5? AK 67P>?597:; 56 L>87@ 5LP7>;M>4

!;?5?8@ *A956@;5 =@;BC6>B D />EFGHI FG

F4 $7?> $LP7>;M56 a 2,$% U9@;M44V


21/35

!;?5?8@ *A956@;5 =@;BC6>B D />EFGHI FH

F4 $7?> $LP7>;M56 a 2,$% U9@;M44V


22/35

!;?5?8@ *A956@;5 =@;BC6>B D />EFGHI FF

F4 $7?> $LP7>;M56 a 2,$% U9@;M44V

• Y>\W +5419B965 8> AKPAM5;975A 8> @?7; ;5MK?56 @A7;MNW9@ kK> M>; A> E?>A>;M>>; T@?L5 T5?L59NKW95 O A> 78>;WQkK> 9@L@M56 E@? AK 59WJ7858 T5?L59@6:


23/35

• Y>X] NB D />EFGHI FI

F4 $7?> $LP7>;M56 a 2,$% U9@;M44V


24/35

!;?5?8@ *A956@;5 =@;BC6>B D />EFGHI F^

21. Apéndice normativo A. Areas de fabricación

Y5P?79597:; O L@;M5j> 8> 8K9M@A

+3@: $LP7>;M56 a 2,$% U9@;M44V


25/35

• _;7858>A "5;>j58@?5A 8> $7?> U_"$V

!;?5?8@ *A956@;5 =@;BC6>B D />EFGHI F`

F4 $7?> $LP7>;M56 a 2,$% U9@;M44V


26/35

• 0>8 8> )K9M@A O 8>LCA 9@LE@;>;M>A4

!;?5?8@ *A956@;5 =@;BC6>B D />EFGHI Fb

F4 $7?> $LP7>;M56 a 2,$% U9@;M44V


27/35

• /7AM>L5] HGG t !;O>997:; D *oM?5997:;

!;?5?8@ *A956@;5 =@;BC6>B D />EFGHI Fe

F4 $7?> $LP7>;M56 a 2,$% U9@;M44V


28/35

• /7AM>L5] 0>97?9K6597:;4 fGt!;O>997:;DFGt*oM?5997:;

!;?5?8@ *A956@;5 =@;BC6>B D />EFGHI Ff

F4 $7?> $LP7>;M56 a 2,$% U9@;M44V


29/35

• U>[ ,5678597:; 8>6 A7AM>L5 2,$%4

• U>[>W *6 A7AM>L5 2,$% 8>P> J56785?A> M@L5;8@ >;9@;A78>?597:; 65 9567Q9597:; 8> 56 L>;@A 6@A

A7;M>A E5?CL>M?@A] I'HK'()IA() L OAH'*)**' /)- 1(')- JA' )/FH'"I)U N+/AH'" *' F"L'..FG" L'aI()..FG" *' )F('U *F['('".F)/'- *' K('-FG" '"I('/)- 1(')-U "bH'(+ *' .)HEF+- *' )F('U .+"I'+ *'

K)(c.A/)-S uKj@A 8> 57?>S ;7J>6>A 8> 67LE7>B5SJ>6@97858 8> uKj@ O E?K>P5A 8> 7;M> $LP7>;M56 a 2,$% U9@;M44V


30/35

• ,5678597:;]

–

%567Q9597:; 8> )7A>m@ – %567Q9597:; 8> !;AM56597:;

– %567Q9597:; 8> 'E>?597:; UO %@LL7AA7@;7; )>A>LE>m@

•

%65A7Q9597:; 8> 3?>5 U$EN;879> $ n .'" G`iV

!;?5?8@ *A956@;5 =@;BC6>B D />EFGHI IG

F4 $7?> $LP7>;M56 a 2,$% U9@;M44V


31/35

• ,5678597:;

!;?5?8@ *A956@;5 =@;BC6>B D />EFGHI IH

F4 $7?> $LP7>;M56 a 2,$% U9@;M44V


32/35

• X>;>Q97@A 8> 65 ,5678597:;]a 'EWL7B5? TK;97@;5L7>;M@ 8>6 A7AM>L5

a ">j@? 9@;@97L7>;M@ 8> ;K>AM?@A E?@9>A@A

a

#5?CL>M?@A %?RW9@A a X5j@ %@;M?@6

a 0>8K997:; 8> T59M@?>A 9@;M5L7;5;M>A 56 E?@8K9M@a *oM>?;@A a !;M>?;@A U9@;M5L7;597:; 9?KB585V

a *Q97>;M5? 65 E?@8K9WJ7858 65P@?56

a

$E@?M> 8> 9567858 5 6@A E?@8K9M@A

a %KLE67L7>;M@ 0>B D />EFGHI IF

F4 $7?> $LP7>;M56 a 2,$% U9@;M44V


33/35

• 0>T>?>;975A X7P67@


34/35

• $ $LP7>;M56 U2,$%V]

?;HE+- -F-I'H)- ('JAF'('" '-I)( N)/F*)*+-2

–

$L:3 1B2L5A 9?RW9@A kK> EK>8>;5T>9M5? 65 95E597858 8> K;5 7;AM56597:;T5?L59NKW95 E5?5 9KLE67? 9@; AK @Pj>WJ@ 8>E?@E@?97@;5? E?@8K9M@ A>Q95B E5?5 >6

E597>;M>4

!;?5?8@ *A956@;5 =@;BC6>B D />EFGHI I^

I4 %@;96KA7:;


35/35

&().F)-

!;?5?8@ *A956@;5 =@;BC6>BA@E@?M>xJ5678597@;y>A9567;L>o79@49@L4Lo

zzz4>A9567;L>o79@49@L4Lo

!;?5?8@ *A956@;5 =@;BC6>B D />EFGHI I`

^4 %@L>;M5?7@A

el impacto de la validacion de sistemas criticos en la calidad de los medicamentos homeopaticos

Documents